a close up of a device: a visualization of DNA in a vial

© Source: Connect world / Shutterstock.com a visualization of DNA in a vial

The market hit a speedbump this week … and the media is playing the fearmongering card in a big way.

a visualization of DNA in a vial

© Provided by InvestorPlace a visualization of DNA in a vial

Was it because of a spike in COVID-19 cases? Because Joe Biden is leading in the polls? Or was it simply a normal and healthy pullback — possibly even a buying opportunity?

I took a poll on Twitter yesterday, and I’ll share my thoughts on the selling in today’s new episode of MoneyLine. But I’ll also go a step further and clue you in on what I did with my own personal money. You just might be surprised.

While the media panicked over the weakness in stocks, bitcoin has continued to break out in a big way. It popped above $13,600 for the first time today since January 2018. Is it too late to get in? I’ll give you my view on bitcoin and cryptocurrencies in general in the podcast.

Then, there was a big deal in the genetic testing sector today related to the future of healthcare. The headline may not sound overly exciting, but after I share the details and name the companies involved, I suspect you’ll join in my excitement.

Remember, I have been high on this sector for a long time now. I launched the Genetic Testing Portfolio in Early Stage Investor just over two years ago and it’s already up an incredible 198% since. Over the same timeframe, the S&P 500 is only up 17%.

Next up I take your questions from Twitter. Today you’ll get my thoughts on a tiny bitcoin mining stock that looks pretty darn good right now… whether it’s time to buy into recent IPO Palantir (NYSE:PLTR) … and a small biotech that has a lot of promise but may be too risky.

Before wrapping up the show I also wanted to rattle off the ticker symbols of some of the stocks that came up in my scans over the weekend. These are small companies with big-time growth potential. I promise you don’t want to miss their names.

All this plus some of our usual witty banter on today’s new episode of MoneyLine. Gotta have a little fun, too, right? Click here to check it out now.

On the date of publication, Matthew McCall did not have (either directly or indirectly) any positions in the securities mentioned in this article.

Matthew McCall left Wall Street to actually help investors — by getting them into the world’s biggest, most revolutionary trends BEFORE anyone else. Click here to see what Matt has up his sleeve now.